{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:25:24Z","timestamp":1788387924456,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["75F40120C00069"],"award-info":[{"award-number":["75F40120C00069"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s11136-024-03847-1","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T05:39:55Z","timestamp":1733290795000},"page":"857-866","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Recalling what we thought we knew about recall periods: a qualitative descriptive study of how adults diagnosed with cancer use recall periods for patient-reported outcome items about physical function"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2941-8999","authenticated-orcid":false,"given":"Theresa","family":"Coles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Plyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexy","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Fillipo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra M.","family":"Henke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Arizmendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Rory","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"LeBlanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Lagoo-Deenadayalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce B.","family":"Reeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin P.","family":"Weinfurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"issue":"7","key":"3847_CR1","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1158\/1078-0432.Ccr-15-2035","volume":"22","author":"PG Kluetz","year":"2016","unstructured":"Kluetz, P. G., Slagle, A., Papadopoulos, E. J., Johnson, L. L., Donoghue, M., Kwitkowski, V. E., Chen, W. H., Sridhara, R., Farrell, A. T., Keegan, P., Kim, G., & Pazdur, R. (2016). Focusing on core patient-reported outcomes in cancer clinical trials: Symptomatic adverse events, physical function, and disease-related symptoms. Clinical Cancer Research, 22(7), 1553\u20131558. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-15-2035","journal-title":"Clinical Cancer Research"},{"issue":"7","key":"3847_CR2","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1007\/s11136-024-03654-8","volume":"33","author":"T Coles","year":"2024","unstructured":"Coles, T., Plyler, K., Hernandez, A., Fillipo, R., Henke, D. M., Arizmendi, C., Lagoo-Deenadayalan, S., Goodwin, C. R., LeBlanc, T. W., Horodniceanu, E. G., Bhatnagar, V., Reeve, B. B., & Weinfurt, K. P. (2024). What facets of physical function are most important to adults diagnosed with cancer? Quality of Life Research, 33(7), 1829\u20131839. https:\/\/doi.org\/10.1007\/s11136-024-03654-8","journal-title":"Quality of Life Research"},{"issue":"4","key":"3847_CR3","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1185\/03007990902774765","volume":"25","author":"DE Stull","year":"2009","unstructured":"Stull, D. E., Leidy, N. K., Parasuraman, B., & Chassany, O. (2009). Optimal recall periods for patient-reported outcomes: Challenges and potential solutions. Current Medical Research and Opinion, 25(4), 929\u2013942. https:\/\/doi.org\/10.1185\/03007990902774765","journal-title":"Current Medical Research and Opinion"},{"issue":"7","key":"3847_CR4","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1007\/s11136-024-03640-0","volume":"33","author":"T Coles","year":"2024","unstructured":"Coles, T., Fillipo, R., Plyler, K., Hernandez, A., Henke, D. M., Arizmendi, C., Cantrell, S., Lagoo-Deenadayalan, S., Rory Goodwin, C., LeBlanc, T. W., Horodniceanu, E. G., Bhatnagar, V., Reeve, B. B., & Weinfurt, K. (2024). Facets of physical function assessed by patient-reported outcome measures in oncology research. Quality of Life Research, 33(7), 1819\u20131828. https:\/\/doi.org\/10.1007\/s11136-024-03640-0","journal-title":"Quality of Life Research"},{"issue":"6","key":"3847_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware, J. E., Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. conceptual framework and item selection. Medical Care, 30(6), 473\u2013483.","journal-title":"Medical Care"},{"issue":"5","key":"3847_CR6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. JMd., Kaasa, S., Klee, M., Osoba, D., Razavi, D., Rofe, P. B., Schraub, S., Sneeuw, K., Sullivan, M., & Takeda, F. (1993). The european organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal National Cancer Institute, 85(5), 365\u2013376. https:\/\/doi.org\/10.1093\/jnci\/85.5.365","journal-title":"Journal National Cancer Institute"},{"issue":"1","key":"3847_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/epirev\/mxx008","volume":"39","author":"TM Atkinson","year":"2017","unstructured":"Atkinson, T. M., Stover, A. M., Storfer, D. F., Saracino, R. M., D\u2019Agostino, T. A., Pergolizzi, D., Matsoukas, K., Li, Y., & Basch, E. (2017). Patient-reported physical function measures in cancer clinical trials. Epidemiologic Reviews, 39(1), 59\u201370. https:\/\/doi.org\/10.1093\/epirev\/mxx008","journal-title":"Epidemiologic Reviews"},{"key":"3847_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jclinepi.2015.08.039","volume":"73","author":"BD Schalet","year":"2016","unstructured":"Schalet, B. D., Hays, R. D., Jensen, S. E., Beaumont, J. L., Fries, J. F., & Cella, D. (2016). Validity of PROMIS physical function measured in diverse clinical samples. Journal of Clinical Epidemiology, 73, 112\u2013118. https:\/\/doi.org\/10.1016\/j.jclinepi.2015.08.039","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"3847_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jval.2021.08.011","volume":"25","author":"JD Peipert","year":"2022","unstructured":"Peipert, J. D., Chapman, R., Shaunfield, S., Kallen, M. A., Schalet, B. D., & Cella, D. (2022). Do you recall?: Results from a within-person recall study of the patient-reported outcomes measurement information system (PROMIS) short form v2.0 - physical function 8c. Value Health, 25(2), 161\u2013166. https:\/\/doi.org\/10.1016\/j.jval.2021.08.011","journal-title":"Value Health"},{"key":"3847_CR10","unstructured":"World Health Organization. World Health Organization disabilty assessment schedule: WHODAS II. Phase 2 field trials. Health services research. 2000."},{"key":"3847_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1477-7525-1-20","volume":"1","author":"B Bruce","year":"2003","unstructured":"Bruce, B., & Fries, J. F. (2003). The stanford health assessment questionnaire: Dimensions and practical applications. Health and Quality of Life Outcomes, 1, 20. https:\/\/doi.org\/10.1186\/1477-7525-1-20","journal-title":"Health and Quality of Life Outcomes"},{"issue":"3","key":"3847_CR12","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s11136-019-02344-0","volume":"29","author":"DM Condon","year":"2020","unstructured":"Condon, D. M., Chapman, R., Shaunfield, S., Kallen, M. A., Beaumont, J. L., Eek, D., Mitra, D., Benjamin, K. L., McQuarrie, K., Liu, J., Shaw, J. W., Martin Nguyen, A., Keating, K., & Cella, D. (2020). Does recall period matter? Comparing PROMIS((R)) physical function with no recall, 24-hr recall, and 7-day recall. Quality of Life Research, 29(3), 745\u2013753. https:\/\/doi.org\/10.1007\/s11136-019-02344-0","journal-title":"Quality of Life Research"},{"key":"3847_CR13","doi-asserted-by":"crossref","unstructured":"Kivunja C, Kuyini AB. Understanding and Applying Research Paradigms in Educational Contexts. Available at: https:\/\/files.eric.ed.gov\/fulltext\/EJ1154775.pdf. Accessed July 25, 2024. International Journal of Higher Education. 2017;6(5):26\u201341.","DOI":"10.5430\/ijhe.v6n5p26"},{"issue":"8","key":"3847_CR14","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick, D. L., Burke, L. B., Gwaltney, C. J., Leidy, N. K., Martin, M. L., Molsen, E., & Ring, L. (2011). Content validity\u2013establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: Part 1\u2013eliciting concepts for a new PRO instrument. Value Health., 14(8), 967\u2013977. https:\/\/doi.org\/10.1016\/j.jval.2011.06.014","journal-title":"Value Health."},{"issue":"8","key":"3847_CR15","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jval.2011.06.013","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick, D. L., Burke, L. B., Gwaltney, C. J., Leidy, N. K., Martin, M. L., Molsen, E., & Ring, L. (2011). Content validity\u2013establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: Part 2\u2013assessing respondent understanding. Value Health., 14(8), 978\u2013988. https:\/\/doi.org\/10.1016\/j.jval.2011.06.013","journal-title":"Value Health."},{"key":"3847_CR16","unstructured":"Patton MQ. Qualitative research & evaluation methods: integrating theory and practice. Fourth edition. ed. Thousand Oaks, California: SAGE Publications, Inc.; 2015."},{"issue":"1","key":"3847_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822X05279903","volume":"18","author":"G Guest","year":"2006","unstructured":"Guest, G., Bunce, A., & Johnson, L. (2006). How many interviews are enough? An experiment with data saturation and variability. Field Methods, 18(1), 59\u201382.","journal-title":"Field Methods"},{"key":"3847_CR18","unstructured":"Willis G. Analysis of the Cognitive Interview in Questionnaire Design. Oxford University Press; 2015."},{"key":"3847_CR19","unstructured":"Matthews J. Review: The Psychology of Survey Response. [Website]. 2011. Available at: https:\/\/www.effortmark.co.uk\/review-psychology-survey-response\/. Accessed September 7, 2023."},{"issue":"4","key":"3847_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1177\/1525822X11416092","volume":"23","author":"GB Willis","year":"2011","unstructured":"Willis, G. B., & Miller, K. (2011). Cross-cultural cognitive interviewing: Seeking comparability and enhancing understanding. Field Methods, 23(4), 331\u2013341.","journal-title":"Field Methods"},{"issue":"9","key":"3847_CR21","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","volume":"15","author":"HF Hsieh","year":"2005","unstructured":"Hsieh, H. F., & Shannon, S. E. (2005). Three approaches to qualitative content analysis. Qualitative Health Research, 15(9), 1277\u20131288. https:\/\/doi.org\/10.1177\/1049732305276687","journal-title":"Qualitative Health Research"},{"issue":"12","key":"3847_CR22","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1007\/s11136-019-02285-8","volume":"28","author":"KP Weinfurt","year":"2019","unstructured":"Weinfurt, K. P. (2019). Viewing assessments of patient-reported heath status as conversations: Implications for developing and evaluating patient-reported outcome measures. Quality of Life Research, 28(12), 3395\u20133401. https:\/\/doi.org\/10.1007\/s11136-019-02285-8","journal-title":"Quality of Life Research"},{"issue":"4","key":"3847_CR23","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jval.2024.01.016","volume":"27","author":"C Arizmendi","year":"2024","unstructured":"Arizmendi, C., Wang, S., Kaplan, S., & Weinfurt, K. (2024). Evaluating recall periods for patient-reported outcome measures: A systematic review of quantitative methods. Value Health., 27(4), 518\u2013526. https:\/\/doi.org\/10.1016\/j.jval.2024.01.016","journal-title":"Value Health."},{"key":"3847_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s40814-019-0475-9","volume":"5","author":"SMS Smith","year":"2019","unstructured":"Smith, S. M. S., Jan, S., Descallar, J., & Marks, G. B. (2019). An investigation of methods to improve recall for the patient-reported outcome measurement in COPD patients: A pilot randomised control trial and feasibility study protocol. Pilot Feasibility Studies, 5, 92. https:\/\/doi.org\/10.1186\/s40814-019-0475-9","journal-title":"Pilot Feasibility Studies"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-024-03847-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-024-03847-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-024-03847-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:41:46Z","timestamp":1742344906000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11136-024-03847-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["3847"],"URL":"https:\/\/doi.org\/10.1007\/s11136-024-03847-1","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,4]]},"assertion":[{"value":"13 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TC has research funding from Merck and Pfizer; a prior consulting agreement with Regenxbio; and received a speaking honorarium from ISPOR. CA was a fellow at Duke (2021\u20132023) funded by AstraZeneca and is now an employee at AstraZeneca (2023-present). CRG is a consultant for Stryker and Medtronic. BBR had a consulting role with Novartis. TWL has received honoraria for consulting\/advisory boards from AbbVie, Agilix, Agios\/Servier, Apellis, Astellas, AstraZeneca, BlueNote, BMS\/Celgene, Genentech, GSK, Lilly, Meter Health, Novartis, and Pfizer; speaking related honoraria from AbbVie, Agios, Astellas, BMS\/Celgene, Incyte, and Rigel; equity interest in Dosentrx (stock options in a privately-held company); royalties from UpToDate; research funding from the AbbVie, American Cancer Society, AstraZeneca, BMS, Deverra Therapeutics, Duke University, GSK, Jazz Pharmaceuticals, and Seattle Genetics. TWL is a Scholar in Clinical Research of the Leukemia & Lymphoma Society. BBR has received honoraria for participating in a meeting with Novartis. All other authors have no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}